Pfaff, RC; Huang, X; Marona-Lewicka, D; Oberlender, R; Nichols, DE. Lysergamides revisited In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1994; pp 52–73. 181 kB. #Table 6 (N-ethyl-N-isopropyl)
Huang, X; Marona-Lewicka, D; Pfaff, RC; Nichols, DE. Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives Pharmacol. Biochem. Behav., 1 Mar 1994, 47 (3), 667–673. 650 kB. https://doi.org/10.1016/0091-3057(94)90172-4 #EIPLA
Nichols, DE. Chemistry and structure–activity relationships of psychedelics In Behavioral Neurobiology of Psychedelic Drugs; Halberstadt, AL; Vollenweider, FX; Nichols, DE, Eds., Springer, 1 Jan 2017; pp 1-43. 2.6 MB. https://doi.org/10.1007/7854_2017_475
Nichols, DE. LSD and its lysergamide cousins Heffter Rev., 1 Jan 2001, 2 (6), 80–87. 265 kB.
Brandt, SD; Kavanagh, PV; Westphal, F; Pulver, B; Schwelm, HM; Stratford, A; Auwärter, V; Halberstadt, AL. Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N6–ethylnorlysergic acid N,N-diethylamide (ETH-LAD) Drug Test. Anal., 15 Jun 2023, n/a (n/a), n/a. 18.9 MB. https://doi.org/10.1002/dta.3530 #EIPLA GC,LC,MS,NMR,IR